Attached files

file filename
EX-31.1 - CERTIFICATION - Glucose Health, Inc.bisu_ex311.htm
EXCEL - IDEA: XBRL DOCUMENT - Glucose Health, Inc.Financial_Report.xls
EX-23.2 - AUDITOR CONSENT - Glucose Health, Inc.bisu_ex232.htm
EX-23.1 - AUDITOR CONSENT - Glucose Health, Inc.bisu_ex231.htm
10-K - FORM 10-K - Glucose Health, Inc.bisu_10k.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Bio-Solutions Corp., a Nevada corporation (the "Company") on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Thomas E. Metzger, Chief Executive Officer/Chief Financial Officer of the Company, certifies to the best of his knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
A signed original of this written statement required by Section 906 has been provided to Bio-Solutions Corp., and will be retained by Bio-Solutions Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
Date: June 25, 2014
By:
/s/ Thomas E. Metzger, PhD  
    Thomas E. Metzger, PhD  
    Chief Executive Officer/Chief Financial Officer